Severe preeclampsia: what’s new in intensive care?

Intensive Care Medicine

Volumn 41, Issue 7, 2015, Pages 1343-1346

  Leone, Marc ^a   Einav, Sharon ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; LABETALOL; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; COMORBIDITY; DELIVERY; DIASTOLIC BLOOD PRESSURE; EVIDENCE BASED PRACTICE; FEMALE; GESTATIONAL AGE; HEART OUTPUT; HEART STROKE VOLUME; HELLP SYNDROME; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MALIGNANT HYPERTENSION; MATERNAL HYPERTENSION; MATERNAL MORTALITY; PREECLAMPSIA; RESPIRATION CONTROL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; EVIDENCE BASED MEDICINE; MORTALITY; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR; TRENDS;

ANTIHYPERTENSIVE AGENTS; CRITICAL CARE; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84933278830     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3701-9     Document Type: Article

References (19)

1. Mhyre JM, Tsen LC, Einav S, Kuklina EV, Leffert LR, Bateman BT (2014) Cardiac arrest during hospitalization for delivery in the United States, 1998–2011. Anesthesiology 120:810–818
2. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2:e323–e333
3. Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH, French National Experts Committee on Maternal Mortality (2013) Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet Gynecol 122:752–760
4. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA (2014) Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS ONE 9:e113715
5. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working Group (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 36:416–441
6. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP, WHO Multicountry Survey on Maternal and Newborn Health Research Network (2014) Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 121(Suppl 1):14–24
7. Taylor J (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 34:2108–2109
8. Moussa HN, Arian SE, Sibai BM (2014) Management of hypertensive disorders in pregnancy. Womens Health (Lond Engl) 10:385–404
9. Haram K, Mortensen JH, Nagy B (2014) Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy 2014:910751
10. Mannucci PM (2015) Understanding organ dysfunction in thrombotic thrombocytopenic purpura. Intensive Care Med [Epub ahead of print]
11. Ronsmans C, Campbell O (2011) Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health 11(Suppl 3):S8
12. Schaap TP, Knight M, Zwart JJ, Kurinczuk JJ, Brocklehurst P, van Roosmalen J, Bloemenkamp KW (2014) Eclampsia, a comparison within the International Network of Obstetric Survey Systems. BJOG 121:1521–1528
13. Dennis AT, Solnordal CB (2012) Acute pulmonary oedema in pregnant women. Anaesthesia 67:646–659
14. European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Lung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197
15. Textoris J, Ivorra D, Ben Amara A, Sabatier F, Ménard JP, Heckenroth H, Bretelle F, Mege JL (2013) Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS ONE 8:e82638
16. Brun C, Zieleskiewicz L, Textoris J, Muller L, Bellefleur JP, Antonini F, Tourret M, Ortega D, Vellin A, Lefrant JY, Boubli L, Bretelle F, Martin C, Leone M (2013) Prediction of fluid responsiveness in severe preeclamptic patients with oliguria. Intensive Care Med 39:593–600
17. Zieleskiewicz L, Contargyris C, Brun C, Touret M, Vellin A, Antonini F, Muller L, Bretelle F, Martin C, Leone M (2014) Lung ultrasound predicts interstitial syndrome and hemodynamic profile in parturients with severe preeclampsia. Anesthesiology 120:906–914
18. Henke VG, Bateman BT, Leffert LR (2013) Focused review: spinal anesthesia in severe preeclampsia. Anesth Analg 117:686–693
19. Yoo KY, Kang DH, Jeong H, Jeong CW, Choi YY, Lee J (2013) A dose-response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int J Obstet Anesth 22:10–18